Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Learn about the clinical utility and limitations of cefdinir, a third-generation cephalosporin antibiotic, in this 13-minute educational presentation by pharmacist Drew Ward. Explore the pharmacokinetic properties that make cefdinir highly bioavailable when taken orally, while examining critical considerations for its appropriate clinical use. Discover why this antimicrobial agent might be considered "Cefdi-nope" in certain clinical scenarios, including discussion of its spectrum of activity, resistance patterns, and optimal prescribing practices. Gain insights into evidence-based decision-making for oral antimicrobial therapy selection, with particular focus on when cefdinir represents an appropriate choice versus when alternative agents might be preferred for infectious disease management.
